Collegium Pharmaceutical (COLL) Operating Leases (2019 - 2026)

Collegium Pharmaceutical has reported Operating Leases for 8 years, with the latest figure at $3.4 million in Q2 2026.

• On a quarterly basis, Operating Leases fell 29.8% year-over-year to $3.4 million in Q2 2026; TTM through Jun 2026 was $3.4 million, a 29.8% decrease from a year earlier, with the FY2025 full-year figure at $4.1 million, down 39.32% from the prior year.
• Operating Leases was $3.4 million for Q2 2026 at Collegium Pharmaceutical, down from $3.8 million in the prior quarter.
• The five-year high for Operating Leases was $7.9 million in Q1 2022, with the low at $3.4 million in Q2 2026.
• Average Operating Leases over 5 years is $5.9 million, with a median of $6.0 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Operating Leases gained 11.2% in 2024, then tumbled 39.32% in 2025.
• Over 5 years, Operating Leases stood at $7.1 million in 2022, then dropped by 13.89% to $6.1 million in 2023, then increased by 11.2% to $6.8 million in 2024, then sank by 39.32% to $4.1 million in 2025, then declined by 17.55% to $3.4 million in 2026.
• The last three Operating Leases figures came in at $3.4 million (Q2 2026), $3.8 million (Q1 2026), and $4.1 million (Q4 2025), per Business Quant data.